MK-677 (ibutamoren) is an oral compound that mimics the hunger hormone ghrelin, triggering your body to release more growth hormone. It does this without injections, which is a key reason it attracts attention in fitness and anti-aging circles. In clinical trials, it has raised 24-hour growth hormone levels by roughly 1.7 to 1.8 times baseline levels, with corresponding increases in IGF-1, the downstream hormone responsible for many of growth hormone’s effects on muscle, bone, and recovery.
MK-677 is not an approved medication. No government health authority has cleared it for human therapeutic use, and it sits on the World Anti-Doping Agency’s prohibited list under growth hormone secretagogues. It remains an investigational compound, available primarily through gray-market supplement sellers.
How MK-677 Works
Your body naturally produces ghrelin, a hormone that rises before meals and signals hunger. Ghrelin also binds to a receptor in the brain called GHSR (the ghrelin receptor), which tells the pituitary gland to release growth hormone in pulses. MK-677 is a synthetic molecule designed to bind that same receptor and flip the same switch, but in pill form rather than as an injectable peptide.
What makes MK-677 distinct from injecting growth hormone directly is that it preserves the body’s natural pulsatile rhythm. Instead of flooding the bloodstream with a flat dose, it amplifies the size of your existing growth hormone pulses while keeping their normal frequency. A built-in feedback loop involving IGF-1 prevents growth hormone from climbing to excessive levels, which is part of why researchers initially considered it a safer alternative to direct growth hormone therapy.
Effects on Growth Hormone and IGF-1
The hormonal changes are well-documented across several clinical trials. In growth hormone-deficient adults, a daily 10 mg dose increased IGF-1 by about 52% and 24-hour mean growth hormone by about 79%. At 50 mg, IGF-1 rose roughly 79% and growth hormone by 82%. In healthy older adults taking 25 mg daily for a year, 24-hour growth hormone output nearly doubled compared to baseline.
These increases brought older adults’ growth hormone secretion closer to what’s typically seen in younger people, which was the original therapeutic rationale. The effects are sustained over months of use rather than fading quickly, though IGF-1 feedback does moderate how high levels climb.
Sleep Quality Improvements
One of the more consistent and notable effects of MK-677 is improved sleep. In younger subjects, it increased deep sleep (stage IV) duration by approximately 50% and REM sleep by more than 20%. Older adults saw an even larger REM sleep boost of nearly 50%, along with faster onset of REM after falling asleep. Since growth hormone is primarily released during deep sleep, these changes likely reinforce each other: more growth hormone improves sleep architecture, and better sleep supports further growth hormone release. For people interested in recovery, this may be the most practically meaningful effect.
Body Composition Changes
The rise in growth hormone and IGF-1 creates conditions that favor lean tissue. Short-term studies have shown increases in fat-free mass, and the compound has been studied specifically for its potential to counter age-related muscle wasting. However, the body composition changes in longer trials have been modest. In the 12-month study of healthy older adults, the results were not dramatic enough to position MK-677 as a standalone muscle-building tool. It shifts the hormonal environment in a favorable direction, but it is not comparable to anabolic steroids or even therapeutic doses of injected growth hormone in terms of raw muscle gain.
Side Effects and Metabolic Risks
Because MK-677 activates the ghrelin receptor, it reliably increases appetite. This is not a subtle effect for most people. If you’re trying to lose fat, a compound that makes you significantly hungrier works against that goal. Water retention and mild swelling are also common, particularly in the first few weeks, as growth hormone influences how your body handles sodium and fluid.
The more serious concern is what MK-677 does to blood sugar. Growth hormone naturally opposes insulin, and sustained elevation can reduce insulin sensitivity. In the year-long trial of older adults, fasting blood glucose increased in the MK-677 group. The researchers noted a small rise in cortisol as well, though they considered it unlikely to fully explain the glucose changes. For anyone with prediabetes, a family history of diabetes, or existing metabolic issues, this is a meaningful risk that compounds over time.
Prolactin elevation has also been reported in some users, which can cause symptoms like breast tissue sensitivity, though this appears less consistent than the appetite and blood sugar effects.
Dosing in Clinical Studies
Most clinical trials used once-daily oral dosing, typically at 10 mg or 25 mg. The compound was selected for research specifically because of its high oral bioavailability and long duration of action, meaning a single daily dose maintains elevated growth hormone pulses throughout the day. The 25 mg dose produced the strongest effects on growth hormone output in healthy elderly subjects, roughly doubling 24-hour secretion after two weeks. Higher doses like 50 mg increased IGF-1 further but with diminishing returns relative to side effects.
Regulatory Status
MK-677 has no approved medical use in any country. It falls under the WADA category of substances with no current approval by any governmental regulatory health authority for human therapeutic use, making it prohibited at all times for competitive athletes, both in and out of competition. Products sold online as “ibutamoren” or “MK-677” are unregulated, which means purity, dosing accuracy, and contamination are genuine concerns. Third-party testing of gray-market compounds routinely finds products that contain less active ingredient than labeled, more than labeled, or different substances entirely.